Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1123542 10.3389/fphar.2022.1123542 Pharmacology Correction Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy Bhagwat et al. 10.3389/fphar.2022.1123542 Bhagwat Geeta S. 1 Athawale Rajani B. 2 * Gude Rajeev P. 3 Md Shadab 4 Alhakamy Nabil A. 4 Fahmy Usama A. 4 Kesharwani Prashant 5 * 1 H. K. College of Pharmacy, Mumbai, India 2 Prin. K. M. Kundanani College of Pharmacy, Mumbai, India 3 Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India 4 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia 5 Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Edited and reviewed by: Kaisar Raza, Central University of Rajasthan, India

 *Correspondence: Prashant Kesharwani, prashantdops@gmail.com; Rajani B. Athawale, rajaniathawale2020@gmail.com

This article was submitted to Drugs Outcomes Research and Policies, a section of the journal Frontiers in Pharmacology

 11 01 2023 2022 13 1123542 14 12 2022 30 12 2022 Copyright © 2023 Bhagwat, Athawale, Gude, Md, Alhakamy, Fahmy and Kesharwani. 2023 Bhagwat, Athawale, Gude, Md, Alhakamy, Fahmy and Kesharwani

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy by Bhagwat G, Athawale RB, Gude RP, Md S, Alhakamy N, Fahmy U and Kesharwani P (2020). Front. Pharmacol. 11:614290. doi: 10.3389/fphar.2020.614290 breast cancer cancer solid lipid nanoparticles tamoxifen targeted drug delivery

In the published article, there was an error in Figure 1 as published. The figure erroneously contained two duplicate images. The corrected Figure 1 and its caption appear below.

Qualitative cell uptake of developed SLN formulations by confocal microscopy.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.